NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment
Today, July 31,2023, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months. Treatments will include drugs, biologics, medical devices and other therapies. […]
NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment Read More »
